Paramesu Biotech Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 26.26 Cr
as on 17-07-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 239.38 Cr
as on 17-07-2024
- Satisfied Charges ₹ 40.00 Cr
as on 17-07-2024
- Revenue 25.92%
(FY 2023)
- Profit -4.25%
(FY 2023)
- Ebitda -5.54%
(FY 2023)
- Net Worth 43.65%
(FY 2023)
- Total Assets 35.87%
(FY 2023)
About Paramesu Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 26.26 Cr.
The company currently has active open charges totaling ₹239.38 Cr. The company has closed loans amounting to ₹40.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Paramesu Biotech Limited India is Sanyukta Jodhani as COMPANY SECRETARY. Krishna Tetali, Upendra Tetali, Ananda Adavani, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232AP2011PLC076378
- Company No.
076378
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Devarapalli, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Paramesu Biotech Limited offer?
Paramesu Biotech Limited offers a wide range of products and services, including Yarns & Threads, Threads, Flavours & Aromatics, Starch Powder, Pharmaceutical Medicine.
Who are the key members and board of directors at Paramesu Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanyukta Jodhani | Company Secretary | 01-Aug-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Tetali  | Director | 07-Sep-2011 | Current |
| Upendra Tetali | Director | 07-Sep-2011 | Current |
| Ananda Adavani | Director | 07-Sep-2011 | Current |
| Satish Tetali | Director | 07-Sep-2011 | Current |
Financial Performance and Corporate Structure Insights of Paramesu Biotech.
Paramesu Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.92% increase. The company also saw a slight decrease in profitability, with a 4.25% decrease in profit. The company's net worth Soared by an impressive increase of 43.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paramesu Biotech?
In 2023, Paramesu Biotech had a promoter holding of 8.59% and a public holding of 91.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Atmanirbhar Poultry Egg Producer Company LimitedActive 1 year 1 month
Upendra Tetali is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 30 Sep 2022 | ₹84.38 Cr | Open |
Indian Bank Creation Date: 11 Mar 2019 | ₹35.00 Cr | Open |
Indian Bank Creation Date: 03 Aug 2013 | ₹120.00 Cr | Open |
How Many Employees Work at Paramesu Biotech?
Paramesu Biotech has a workforce of 349 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paramesu Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paramesu Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
